SWP
CLB icon

Stratos Wealth Partners’s Core Laboratories CLB Stock Holding History

Stratos Wealth Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-320
Closed -$37K – 1086
2018
Q3 		$37K Buy
+320
New +$36.1K ﹤0.01% 1593
2018
Q2 		– Sell
-1,108
Closed -$120K – 1230
2018
Q1 		$120K Buy
1,108
+116
+12% +$12.8K 0.01% 1102
2017
Q4 		$109K Buy
+992
New +$99K ﹤0.01% 1144

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Stratos Wealth Partners's CLB Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 320 shares — an estimated $37K sold.

Stratos Wealth Partners first reported a position in CLB in Q4 2017 and held it in 3 quarters. The position peaked at $120K in Q1 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 320 Core Laboratories shares in Q4 2018, an estimated $37K.
  • Stratos Wealth Partners first reported a position in Core Laboratories in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Core Laboratories position peaked at $120K in Q1 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.